TERMIS-AM 2025
Detriot, MI Detroit, MI, United StatesARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
ARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
BioFabUSA will exhibit and present at DMC 2025, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
ARMI sponsors Rockwell Automation Fair 2025 to explore smart manufacturing technologies and digital transformation in biomanufacturing and regenerative medicine.
ARMI will attend RAPID + TCT 2026 to explore the intersection of additive manufacturing and biomanufacturing, driving innovation in regenerative healthcare solutions.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
